Apollomics
APLM | NASDAQ
$17.84
+$0.16 (+0.90%)
At close: Nov 16, 2026, 4:00 PM ET
$17.51
-$0.33 (-1.85%)
After-hours:
Nov 16, 2026, 7:30 PM ET
Apollomics Company Profile
Company profile explainedCompany Profile
Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements. Its therapeutic pipeline features APL-101 (Vebreltinib), a potent and selective c-Met inhibitor being developed for non-small cell lung cancer and other advanced malignancies. Also in development is APL-102, an orally administered, small molecule multiple tyrosine kinase inhibitor intended for liver, breast, and esophageal cancers. Furthermore, APL-122 is an investigational tumor inhibitor candidate focused on treating cancers within the brain. The organization was formerly known as CBT Pharmaceuticals, Inc. before adopting the name Apollomics, Inc. in January 2019.
Key Executives
| Name | Position |
|---|---|
| Hung-Wen Chen | Chief Executive Officer & Chairman of the Board |
| K. H. Lin | Chief Financial Officer |
| Yi-Kuei Chen | Director & Chief Operating Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 24, 2026 | 4/A | [Amend] Filing |
| Sep 24, 2026 | 4/A | [Amend] Filing |
| Sep 24, 2026 | 4/A | [Amend] Filing |
| Sep 17, 2026 | 4 | Filing |
| Sep 17, 2026 | 4 | Filing |
| Sep 17, 2026 | 4 | Filing |
| Sep 17, 2026 | 4 | Filing |
| Sep 17, 2026 | 4 | Filing |
| Sep 17, 2026 | 4 | Filing |
| Sep 17, 2026 | 4 | Filing |
Apollomics
| Country | United States |
| IPO Date | Nov 26, 2021 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 14 |
| CEO | Hung-Wen Chen |
Contact Details
989 East Hillsdale Blvd Foster City,
California 94404 United States
Stock Details
| Ticker Symbol | APLM |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001944885 |
| CUSIP Number | G0411D123 |
| ISIN Number | KYG0411D1236 |
| SIC Code | 2834 |
Add to Watchlist
Select watchlists to add or remove APLM